Role of adipocytokines in obesity-associated insulin resistance.
The rapid increase of obese population in the United States has made obesity into epidemic proportion. Obesity is a strong risk factor for metabolic syndrome, type 2 diabetes mellitus, cardiovascular diseases, cancer and other diseases. Compelling evidence has demonstrated that increased adipose tissue mass is not only the consequence of obesity, but also plays a central role in the development of obesity-associated diseases. Recent studies have profoundly changed the concept of adipose tissue from being an energy depot to an active endocrine organ. The development of obesity alters adipocyte-derived hormones or cytokines expression, which provide a link between obesity and impaired insulin sensitivity and metabolic defects in other tissues. This review summarizes the current knowledge on how major adipose-derived hormones or adipocytokines influence insulin sensitivity.
Zou
Chenhui
C
Graduate Center for Nutritional Sciences, University of Kentucky, Lexington, KY 40536, USA.
Shao
Jianhua
J
D054392:Adipokines / Q000502:physiology*; D000273:Adipose Tissue / Q000502:physiology; D006801:Humans; D007333:Insulin Resistance; D009765:Obesity / Q000503:physiopathology*
D054392:Adipokines